Banco Bilbao Vizcaya Argentaria S.A. reduced its position in MetLife, Inc. (NYSE:MET - Free Report) by 32.2% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 21,180 shares of the financial services provider's stock after selling 10,075 shares during the period. Banco Bilbao Vizcaya Argentaria S.A.'s holdings in MetLife were worth $1,734,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Transce3nd LLC purchased a new stake in MetLife in the 4th quarter worth approximately $26,000. Sierra Ocean LLC purchased a new stake in shares of MetLife during the 4th quarter valued at $32,000. Retirement Wealth Solutions LLC purchased a new stake in shares of MetLife during the 4th quarter valued at $32,000. Graney & King LLC purchased a new stake in shares of MetLife during the 4th quarter valued at $34,000. Finally, Values First Advisors Inc. purchased a new stake in shares of MetLife during the 4th quarter valued at $36,000. 94.99% of the stock is owned by hedge funds and other institutional investors.
MetLife Stock Performance
Shares of MET stock opened at $75.23 on Monday. MetLife, Inc. has a 12 month low of $65.21 and a 12 month high of $89.05. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.16 and a quick ratio of 0.16. The firm has a market capitalization of $51.25 billion, a P/E ratio of 12.60, a P/E/G ratio of 0.65 and a beta of 0.89. The company's fifty day moving average price is $78.35 and its two-hundred day moving average price is $81.78.
MetLife (NYSE:MET - Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing analysts' consensus estimates of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. On average, research analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.
MetLife Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 10th. Investors of record on Tuesday, May 6th will be issued a $0.5675 dividend. This is a positive change from MetLife's previous quarterly dividend of $0.55. This represents a $2.27 annualized dividend and a yield of 3.02%. The ex-dividend date of this dividend is Tuesday, May 6th. MetLife's payout ratio is currently 38.02%.
Analysts Set New Price Targets
Several analysts have recently issued reports on the stock. Keefe, Bruyette & Woods lowered their price objective on shares of MetLife from $98.00 to $95.00 and set an "outperform" rating for the company in a research note on Wednesday, April 9th. Barclays lowered their price objective on shares of MetLife from $95.00 to $88.00 and set an "overweight" rating for the company in a research note on Friday, April 11th. Morgan Stanley lowered their price objective on shares of MetLife from $109.00 to $94.00 and set an "overweight" rating for the company in a research note on Thursday, April 10th. UBS Group upped their price target on shares of MetLife from $94.00 to $98.00 and gave the stock a "buy" rating in a research report on Wednesday, April 2nd. Finally, BMO Capital Markets initiated coverage on shares of MetLife in a research report on Thursday, January 23rd. They set a "market perform" rating and a $97.00 price target for the company. Two investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat, MetLife currently has an average rating of "Moderate Buy" and a consensus target price of $92.46.
Check Out Our Latest Stock Report on MetLife
MetLife Company Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
